Covid-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the covid-19 vaccination in autoimmune diseases (covad) survey

HIGHLIGHTS

• who: Leonardo Santos Hoff from the India India have published the paper: COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey, in the Journal: Rheumatology International (2023) 43:47-58 of /2023/
• what: The authors aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs other systemic autoimmune and inflammatory diseases (SAIDs) and healthy controls (HCs). Methods This is a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.